ATE261425T1 - Erythromycin-derivate mit antibiotischer wirkung - Google Patents

Erythromycin-derivate mit antibiotischer wirkung

Info

Publication number
ATE261425T1
ATE261425T1 AT99938386T AT99938386T ATE261425T1 AT E261425 T1 ATE261425 T1 AT E261425T1 AT 99938386 T AT99938386 T AT 99938386T AT 99938386 T AT99938386 T AT 99938386T AT E261425 T1 ATE261425 T1 AT E261425T1
Authority
AT
Austria
Prior art keywords
erythromycin derivatives
antibiotic action
erythromycin
derivatives
antibiotic
Prior art date
Application number
AT99938386T
Other languages
English (en)
Inventor
Franco Pellacini
Daniela Botta
Enrico Albini
Domenico Ungheri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE261425T1 publication Critical patent/ATE261425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99938386T 1998-07-30 1999-07-27 Erythromycin-derivate mit antibiotischer wirkung ATE261425T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001776A IT1301968B1 (it) 1998-07-30 1998-07-30 Derivati di eritromicina ad attivita' antibiotica
PCT/EP1999/005485 WO2000006606A2 (en) 1998-07-30 1999-07-27 Erythromycin derivatives with antibiotic activity

Publications (1)

Publication Number Publication Date
ATE261425T1 true ATE261425T1 (de) 2004-03-15

Family

ID=11380563

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938386T ATE261425T1 (de) 1998-07-30 1999-07-27 Erythromycin-derivate mit antibiotischer wirkung

Country Status (8)

Country Link
US (1) US6468979B1 (de)
EP (1) EP1100762B1 (de)
AT (1) ATE261425T1 (de)
AU (1) AU5290199A (de)
DE (1) DE69915487T2 (de)
ES (1) ES2215396T3 (de)
IT (1) IT1301968B1 (de)
WO (1) WO2000006606A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) * 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) * 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
WO2004078770A1 (en) * 2003-03-05 2004-09-16 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using the same
AU2004242847B2 (en) 2003-05-31 2011-06-09 Amgen Research (Munich) Gmbh Pharmaceutical composition comprising a bispecific antibody for EpCAM
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP1934238B1 (de) 2005-08-24 2017-06-28 Melinta Therapeutics, Inc. Triazolverbindungen und verfahren zur herstellung und verwendung davon
US9173396B2 (en) 2010-10-22 2015-11-03 Bayer Intellectual Property Gmbh Heterocyclic compounds as pesticides
EP3303332A1 (de) 2015-06-01 2018-04-11 Bantam Pharmaceutical, LLC Substituierte pyrazol- und pyrrolverbindungen sowie verfahren zur verwendung davon zur hemmung der einleitung von translation und behandlung von erkrankungen und leiden im zusammenhang damit
CN110603254B (zh) 2016-11-30 2024-04-12 班塔姆制药有限责任公司 被取代的吡唑化合物以及使用其治疗过度增生性疾病的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica

Also Published As

Publication number Publication date
AU5290199A (en) 2000-02-21
EP1100762B1 (de) 2004-03-10
ITMI981776A0 (it) 1998-07-30
ITMI981776A1 (it) 2000-01-30
US6468979B1 (en) 2002-10-22
ES2215396T3 (es) 2004-10-01
DE69915487T2 (de) 2005-02-17
WO2000006606A3 (en) 2000-05-04
IT1301968B1 (it) 2000-07-20
EP1100762A2 (de) 2001-05-23
DE69915487D1 (de) 2004-04-15
WO2000006606A2 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
IL166527A0 (en) Macrolide compounds endowed with antiinflammatory activity
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
PT876388E (pt) Derivados de eritromicina triciclica
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
CA2326222A1 (en) Medicinal compositions
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
DE69222698D1 (de) 4-desoxy-4-epipodophyllotoxinderivate oder deren pharmazeutisch akzeptierbaren salze
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
FI945164A0 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
EP1059304A4 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
DE69912959D1 (de) Eythromycinderivat mit antibiotischer aktvität
MX9203221A (es) Compuesto farmacologicamente activo, preparacion y empleo.
DE68908838T2 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
DK1086695T3 (da) Antivirale præparater omfattende yohimbin som aktivt princip
HUP9801085A3 (en) Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient
DK1236726T3 (da) Triazaspiro[5.5]undecan-derivater og lægemidler indeholdende samme som den aktive bestanddel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties